quinoxalines has been researched along with avanafil in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Himiyama, T; Hongu, M; Kadoh, Y; Kawanishi, E; Kimura, M; Kobayashi, T; Kojima, K; Kotera, J; Matsumura, T; Miyoshi, H; Omori, K; Sakamoto, T; Sasaki, T; Takedomi, K; Tanaka, Y; Taniguchi, H; Watanabe, Y | 1 |
1 other study(ies) available for quinoxalines and avanafil
Article | Year |
---|---|
Discovery of 2-[(E)-2-(7-Fluoro-3-methylquinoxalin-2-yl)vinyl]-6-pyrrolidin-1-yl-N-(tetrahydro-2H-pyran-4-yl)pyrimidin-4-amine Hydrochloride as a Highly Selective PDE10A Inhibitor.
Topics: Animals; Avoidance Learning; Binding Sites; Crystallography, X-Ray; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Molecular Dynamics Simulation; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrimidines; Quinoxalines; Rats; Structure-Activity Relationship | 2018 |